Portage Biotech Inc (PRTG) saw an uptrend of 4178489% in the recent trading with $1350000.0 being its most recent. The current price level -73.45% lower than the highest price of $23.01 marked by the stock while trading over the past 52-weeks, whereas it is 191.23% higher than the lowest price of $2.10 the company dropped to over past 52-weeks. The latest news story on PRTG appeared in (GlobeNewswire) under the title “Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements” on Today.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Hold by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.
Portage Biotech Inc Earnings – What Happened With PRTG
Coming around sales and income figures on PRTG Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Portage Biotech Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.12 million. PRTG does have institutional investors; and they hold 2.76% of the stock.
As on 2024-06-30, ARMISTICE CAPITAL, LLC was the top most holder in Portage Biotech Inc (NASDAQ:PRTG) with an ownership of 1.5 million shares of the company or 7.1866 of the stake worth $0.32 million. The filing also reveals as the second largest holder in the company with a control over 1.4247 of the outstanding shares. Its stake is worth $71514.0 for having 0.3 million shares in hand.
BISON WEALTH, LLC also came holding a key position in the company during the recent quarter and it now holds 1.0212 of the outstanding shares. With this there are now 22.0 institutions which have possession in PRTG’s shares.
Key Metrics forPRTG
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Portage Biotech Inc has a debt to equity ratio of 0.02.
Technical Analysis of Portage Biotech Inc (NASDAQ:PRTG) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Portage Biotech Inc (PRTG), we notice that the stock’s 20-day average volume is at 231,015 shares. Medium term indicators at an average of 50% are spotting the stock at Buy with its 50-day average volume of 479,568 shares. And to end, PRTG’s 100-day average volume is 916,225 shares with 50% of the long-term indicators pointing towards Buy for the stock.
